Search - tctmd.com

Displaying 201 - 220 of 4486

Sort: Relevancy | Date

News Daily News

Elevated Lp(a), Even in Statin-Treated Patients, Linked With Higher CVD Risks

Michael O'Riordan

October 15, 2018

News Opinion Editor's Corner TCT 2018

My Takeaways From TCT 2018: Sunglasses, Shadows, and the COAPT Eclipse

Shelley Wood

October 12, 2018

News Daily News

Weekend Discharge Not Linked to More Readmissions After Cardiac Surgery

Michael O'Riordan

October 12, 2018

News Daily News

Gender Gap May Be Narrowing in ACS Patients, With Mortality Advantage for Elderly Women

L.A. McKeown

October 12, 2018

Presentation CDM 2018

The Hope and Promise of Renal Denervation

Presenter: Michael A.Weber

October 12, 2018

Presentation CDM 2018

Comparing the Hypertension Guidelines: Resolving the Controversies

Presenter: Michael A.Weber

October 12, 2018

Presentation CDM 2018

The Pregnant Patient With Unstable Angina: Special Concerns, Evaluation and Treatment Options

Presenter: Poulina Q. Uddin

October 12, 2018

Presentation CDM 2018

With the Explosion in Growth of HF, What is the Role of an Outpatient Oriented HF Clinic in Your Practice?

Presenter: Nancy K. Sweitzer

October 12, 2018

Presentation CDM 2018

We Have a HF Epidemic: New Agents and New Promises

Presenter: Nancy K. Sweitzer

October 12, 2018

Presentation CDM 2018

What About PFO Closure for Migraines, is There Convincing Evidence to Treat?

Presenter: Robert J. Sommer

October 12, 2018

Presentation CDM 2018

New Treatments for Peripheral Artery Disease: What Practitioners Need to Know

Presenter: John R. Laird

October 12, 2018

Presentation CDM 2018

Abdominal and Thoracic Aneurysmal Disease: Best Treated Percutaneously

Presenter: JohnR .Laird

October 12, 2018

Presentation CDM 2018

Digital Medicine: The Promise and Peril of a Connected Future

Presenter: Raj Khandwalla

October 12, 2018

Presentation CDM 2018

Does This Really Change Our Treatment of Chronic Stable Angina?

Presenter: Kirk N. Garratt

October 12, 2018

Presentation CDM 2018

Cardiovascular Outcomes Trials (CVOT): Latest Results and Recommendations

Presenter: Dailey George

October 12, 2018

Bioprosthetic structural valve degeneration

Presentation CDM 2018

TAVR is Here to Stay: What About TAVR in Low-Risk Patients?

Presenter: Joseph P. Carrozza

October 12, 2018

Presentation CDM 2018

Are We Recognizing all of the Treatable Causes of Hypertension?

Presenter: J Brian Byrd

October 12, 2018

Presentation

Atrial Fibrillation: What Is the Best Approach to Treat and Control? A Practical Approach

Presenter: T. Jared Bunch

October 12, 2018

Presentation CDM 2018

Beyond Limb Salvage: Life Salvage

Presenter: Alan J. Block

October 12, 2018

News Daily News

FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients

Todd Neale

October 12, 2018

Advertisement

Elevated Lp(a), Even in Statin-Treated Patients, Linked With Higher CVD Risks

My Takeaways From TCT 2018: Sunglasses, Shadows, and the COAPT Eclipse

Weekend Discharge Not Linked to More Readmissions After Cardiac Surgery

Gender Gap May Be Narrowing in ACS Patients, With Mortality Advantage for Elderly Women

The Hope and Promise of Renal Denervation

Comparing the Hypertension Guidelines: Resolving the Controversies

The Pregnant Patient With Unstable Angina: Special Concerns, Evaluation and Treatment Options

With the Explosion in Growth of HF, What is the Role of an Outpatient Oriented HF Clinic in Your Practice?

We Have a HF Epidemic: New Agents and New Promises

What About PFO Closure for Migraines, is There Convincing Evidence to Treat?

New Treatments for Peripheral Artery Disease: What Practitioners Need to Know

Abdominal and Thoracic Aneurysmal Disease: Best Treated Percutaneously

Digital Medicine: The Promise and Peril of a Connected Future

Does This Really Change Our Treatment of Chronic Stable Angina?

Cardiovascular Outcomes Trials (CVOT): Latest Results and Recommendations

TAVR is Here to Stay: What About TAVR in Low-Risk Patients?

Are We Recognizing all of the Treatable Causes of Hypertension?

Atrial Fibrillation: What Is the Best Approach to Treat and Control? A Practical Approach

Beyond Limb Salvage: Life Salvage

FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content